CAMP4 Therapeutics (CAMP)

• Market cap: $186M
• 1 day: 1.41%
• 5 days: -6.27%
• 1 month: -40.07%
• 3 months: -13.7%
• 6 months: 114.97%
• Year to date: -40.17%
• 1 year: -30.69%
• 5 years: -66.51%
• 10 years: -66.51%
• Sector: Healthcare
• Industry: Biotechnology

About: Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.

Employees: 55